We share a glimpse into our Project Closing Meeting from last September, where five centers from our network - Technical University of Munich, University of Bern, University Hospital Ramón y Cajal #IRYCIS, University Hospital Basel, and CHU de Lille - came together to discuss our joint ongoing research into prostate cancer. Hear about their experiences and insights on this groundbreaking partnership, on how we’re advancing therapies for high-risk and localized prostate cancer, leveraging AI to analyze vast datasets and design smarter, more patient-centered clinical trials.
